T. Fujimaki et al., PROLIFERATIVE ACTIVITY OF CENTRAL NEUROCYTOMA - MEASUREMENT OF TUMOR VOLUME DOUBLING TIME, MIB-1 STAINING INDEX AND BROMODEOXYURIDINE LABELING INDEX, Journal of neuro-oncology, 32(2), 1997, pp. 103-109
Central neurocytoma is considered to be a benign intracranial neoplasm
, but little is known about the biological behavior of this type of tu
mor. Proliferative activity of central neurocytoma was measured in 10
cases using MIB-1 staining for Ki-67 antigen. The MIB-1 staining value
varied from < 0.1% to 5.6%, to indicating that some of these tumors h
ave proliferative potential similar to that of anaplastic astrocytoma
or malignant meningioma. The bromodeoxyuridine labeling index (BUdR LI
, BrdU LI) was measured in 2 cases and the results correlated well wit
h those of the MIB-1 analysis. Tumor volume doubling time (Td) measure
d in one case was 358 days which is similar to that of malignant menin
gioma. In one case, the MIB-1 value taken before and after 58 Gy of ra
diation treatment decreased markedly from 5.6% to 0.2%. The other 9 ca
ses were also treated by radiation therapy (50-60 Gy) and no tumor rec
urrence was observed during follow-up periods ranging from 23 to 160 m
onths. Another two patients with partially removed and 3 with subtotal
ly removed tumors showing relatively high MIB-1 values might also have
benefited from radiation therapy.